Internal Medicine, Endocrinology, Diabetes, & Metabolism · New York, NY
NPI
1477896066
Since 2013
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
110 E 59th St, Suite 8b
New York, NY, 10022
Phone (212) 434-3550
Groups this clinician bills Medicare through
Medicare paid, 2024
$43K
416 services
Medicare patients, 2024
178
Average age 74
Drug cost, 2024
$469K
1,636 prescriptions
Company payments, 2024
$41.22
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Karin Chen was code 99214 (office e&m - established), 166 times for 82 patients. In total Karin Chen billed 416 services in 14 codes, and Medicare paid $43K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-01-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 166 | 82 | $107.19 | $18K |
| 99232 Hospital E&M - Subsequent | Facility | 104 | 50 | $69.80 | $7,259 |
| 99215 Office E&M - Established | Office | 45 | 33 | $150.90 | $6,790 |
| 99222 Hospital E&M - Initial | Facility | 44 | 43 | $113.88 | $5,011 |
| 99204 Office E&M - New | Office | 15 | 15 | $152.34 | $2,285 |
By year: 2022 $40K for 350 services; 2023 $43K for 405 services; 2024 $43K for 416 services.
Medicare prescription drug claims, 2024
In 2024, the drug Karin Chen prescribed most often to Medicare patients was Metformin Hcl, with 125 prescriptions and refills. In total Karin Chen wrote 1,636 Medicare prescriptions that cost $469K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metformin Hcl Generic | 125 | 230 | 32 | $596 |
| Levothyroxine Sodium Generic | 114 | 189 | 23 | $642 |
| Mounjaro Tirzepatide | 94 | 116 | 15 | $123K |
| Repaglinide Generic | 76 | 126 | 20 | $2,212 |
| Ozempic Semaglutide | 69 | 77 | 14 | $67K |
| Synthroid Levothyroxine Sodium | 60 | 102 | 11 | $3,136 |
| Metformin Hcl Er Metformin Hcl | 57 | 103 | 15 | $654 |
| Tresiba Flextouch U-100 Insulin Degludec | 50 | 88 | 12 | $16K |
| Novolog Flexpen Insulin Aspart | 49 | 70 | 15 | $7,507 |
| Pioglitazone Hcl Generic | 48 | 56 | Under 11 | $215 |
| Jardiance Empagliflozin | 48 | 73 | 12 | $43K |
| Trulicity Dulaglutide | 46 | 53 | Under 11 | $53K |
| Atorvastatin Calcium Generic | 39 | 73 | 13 | $282 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 33 | 80 | 16 | $3,306 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 33 | 76 | Under 11 | $2,716 |
Brand drugs: 728 claims; generic drugs: 737 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Karin Chen $41.22 ($41.22 in general payments such as food, travel and fees) from 2 companies. The largest payer was Abbott Laboratories with $21.46.
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories ABT | 1 | $21.46 |
| Xeris Pharmaceuticals, Inc. | 1 | $19.76 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.